THE TIP OF THE SPEAR: NATURE’S FIRST RESPONDER™

OF OUR COMPREHENSIVE ONCOLOGY PIPELINE

haNK® and t-haNKTM
THE NANT CANCER VACCINE
Harnessing the Power of Our Immune System

THE TIP OF THE SPEAR: NATURE’S FIRST RESPONDER™

OF OUR COMPREHENSIVE ONCOLOGY PIPELINE

haNK®, and t-haNK™
THE NANT CANCER VACCINE
Harnessing the Power of Our Immune System

Pipeline

Pipeline

Clinical Trials with Cryopreserved haNK®

Triple Negative Breast Cancer (QUILT 3.067)

haNK + avelumab + NCV NCT# 03387085

Head & Neck and Squamous Non-Small Cell Lung Cancer (QUILT 3.090)

haNK + avelumab/necitumumab + NCV NCT# 03387111

Pancreatic Cancer (QUILT 3.080)

haNK + avelumab + NCV NCT# 03586869

Clinical Trials with Cryopreserved t-haNK™

Advanced Heme Malignancies

CD-19.t-haNK + avelumab/rituximab + NCV NCT# TBD  

Advanced Solid Tumors

PDL1.t-haNK + avelumab + NCV NCT# TBD

Her2+ Solid Tumor

Her2/EGFR.t-haNK + avelumab + NCV NCT# TBD

To learn more about the Nant Cancer Vaccine

To learn more about our clinical trials

*Reliant on Safety from Phase I dosing of haNK monotherapy and aNK or haNK in pancreatic + NCV


CONTACT NANTKWEST
CLICK HERE

NK-92 ®️ CELLS FOR ASSAYS
CLICK HERE